Investors – Calliditas Therapeutics AB

Share Price: Sweden

Share Price: US

Interim Report Q3 2022

On November 14, 2022, at 07:00 CEST, Calliditas Therapeutics published its interim report for the third quarter 2022.

Audio cast with teleconference: November 14, 2022, at 14:30 CET

Read the report

IR Calendar

Feb 23, 2023Year-end report for the period January 1 – December 31, 2022
May 17, 2023Interim Report for the period January 1 – March 31, 2023

Press releases

Nov 15, 2022Calliditas’ partner Everest Medicine’s New Drug Application for Nefecon is accepted by the China NMPA
Nov 14, 2022Interim Report Q3, 2022
Nov 7, 2022Key Opinion Leader Fireside Chat with Professor Richard Lafayette on the US IgAN Treatment Landscape

All press releases